The interface between psychogenic and organic difficulties in men with erectile dysfunction

References

• Andrade , R. and Aghajanian , G. K. 1982 . Single cell activity in the noradrenergic A5 region: responses to drugs and peripheral manipulation of blood pressure . Brain Research , 242 : 125 – 135 .
   PubMedGoogle Scholar
• Barada , J. H. and McKimmy , R. M. 1994 . “ Vasoactive pharmacotherapy ” . In Impotence: Diagnosis and Management of Erectile Dysfunction , Edited by: Bennett , A. H. London : W.B. Saunders .
   Google Scholar
• Bloomfield , M. . The general practitioner's involvement with erectile dysfunction . paper presented at the Conference on Erectile Dysfunction Promoting the Quality of Life . Bristol.
   Google Scholar
• Brindley , G. S. 1983 . Cavernosal alpha-blockade: a new treatment for investigating and treating erectile impotence . British Journal of Psychiatry , 143 : 332 – 337 .
   PubMed Web of Science ®Google Scholar
• Brindley , G. S. 1996 . Intrapenile drug delivery systems . International Journal of STD & AIDS , 7 ( suppl. 3 ) : 13 – 15 .
   PubMed Web of Science ®Google Scholar
• Charney , D. S. , Heninger , G. R. and Sternberg , D. E. 1982 . Assessment of alpha2 adrenergic autoregulator function in humans: effect of oral yohimbine . Life Sciences , 30 : 2033 – 2041 .
   PubMed Web of Science ®Google Scholar
• Costa , P. , Jaccovella , J. and Bouvet , A. . Efficacy and tolerability of moxisylyte and placebo injected intracavernously in patients with erectile dysfunction (ED): a multicentre double-blind study . paper presented at the British Erectile Disorder Society Annual Conference . Stratford on Avon.
   Google Scholar
• Eardley , L. . Pills for potency . paper presented at the conference on Erectile Dysfunction. Promoting the Quality of Life . Bristol, UK.
   Google Scholar
• Evans , C. 1997 . Personal communication
   Google Scholar
• Feldman , H. A. , Goldstein , T. , Hatzichristou , D. O. , Krane , R. J. and McKinlay , J. E. 1994 . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study . Journal of Urology , 151 : 54 – 61 .
   PubMed Web of Science ®Google Scholar
• Gingell , C. , Jardin , A. , Giuliano , F. A. , Olsson , A. M. , Dinsmore , W. W. Osterloh , I. H. 1996 . The efficacy of sildenafil (Viagra), a new oral treatment for erectile dysfunction, demonstrated by four different methods in a double-blind placebo-controlled, multinational clinic trial (abstract) . European Urologist , 30 ( suppl. 2 ) : 353
   Google Scholar
• Goldberg , M. R. and Robertson , D. 1983 . Yohimbine: a pharmacological probe for the study of the alpha2 adrenoceptor . Pharmacological Reviews , 35 : 143 – 180 .
   PubMed Web of Science ®Google Scholar
• Hermabessiere , J. , Costa , P. and Andro , M.-C. 1995 . Efficacy and safety of moxisylyte by intracavernous injections in patients with erectile dysfunction: double-blind placebo-controlled study . Progrès en Urologie , 5 : 985 – 991 .
   PubMedGoogle Scholar
• Holmes , S. , Kirby , R. and Carson , C. 1997 . Male Erectile Dysfunction , Oxford : Health Press .
   Google Scholar
• Ishii , N. , Watanabe , H , Irisawa , C. , Kikuchi , Y , Kawamura , S. , Suzuki , K. , Chiba , R. , Tokiwa , M. and Shirai , M. 1986 . Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence . Japanese Journal of Urology , 77 : 954 – 962 .
   PubMedGoogle Scholar
• Karbe , K. 1990 . Potaba-Glenwood in the treatment of Peyronie's disease . UROSCOP , 1 : 3 – 10 .
   Google Scholar
• Kolaja , G. J. and Kirton , K. T. 1993 . “ Toxicology studies with alprostadil ” . In The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction , Edited by: Goldstein , L. and Lue , T. F. 40 – 50 . Princetown, NJ : Excerpta Medica .
   Google Scholar
• Linet , O. L. and Ogring , F. G. 1996 . Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction . The New England Journal of Medicine , 334 : 873 – 877 .
   PubMed Web of Science ®Google Scholar
• Meinhardt , W. , Lycklama , A. , Nijeholt , A. A.B. , Kropman , R. F. and Zwartendijk , J. 1993 . The negative pressure device for erectile disorders: when does it fail? . Journal of Urology , 149 : 1285 – 1287 .
   PubMed Web of Science ®Google Scholar
• Nadig , P. 1986 . Utility of the vacuum-constriction device for men who have failed penile prostheses . Journal of Urology , 135 : 232A part 2
   Google Scholar
• Navratil , H. , Costa , P. , Louis , J-F. , Andro , M-C. and Saur , P. 1995 . Efficacy and safety of intracavernous injection of moxisylyte in patients with erectile dysfunction dose/effect relationship versus placebo . Progrès en Urologie , 5 : 690 – 696 .
   PubMedGoogle Scholar
• Nelson , R. P. 1988 . Nonoperative management of impotence . Journal of Urology , 139 : 2 – 5 .
   PubMed Web of Science ®Google Scholar
• O'Keefe , M. and Hunt , D. K. 1985 . Assessment and treatment of impotence . Medical Clinician of North America , 79 : 415 – 434 .
   Google Scholar
• Padma-Nathan , H. , Hellstrom , W. J.G. , Kaiser , F. , Labasky , R. F. , Lui , T. F. , Nolten , W. E. , Norwood , P. , Peterson , C. A. , Shabsigh , R. , Tam , P. Y. , Place , V. A. and Gesundheit , N. 1997 . Treatment of men with erectile dysfunction with transurethral alprostadil . The New England Journal of Medicine , 336 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Price , D. . Vacuum devices . paper presented at the conference on Erectile Dysfunction: Promoting the Quality of Life . Bristol.
   Google Scholar
• Price , L. H. , Charney , D. S. and Heninger , G. R. 1984 . Three cases of manic symptoms following yohimbine administration . American Journal of Psychiatry , 141 : 1267 – 1268 .
   PubMed Web of Science ®Google Scholar
• Reid , K. , Surridge , D. H.C. , Morales , A. , Condra , M. , Harris , C. , Owen , J. and Fenmore , J. 1987 . Double-blind trial of yohimbine in treatment of psychogenic impotence . Lancet , : 421 – 423 .
   PubMedGoogle Scholar
• Riley , A. J. , Goodman , R. E. , Kellett , J. M. and Orr , R. 1989 . Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy . Sexual and Marital Therapy , 4 : 17 – 26 .
   Google Scholar
• Sonda , L. P. 1990 . The role of yohimbine for the treatment of erectile impotence . Journal of Sex and Marital Therapy , 16 : 15 – 21 .
   PubMed Web of Science ®Google Scholar
• Susset , J. G. , Tesser , C. D. , Wincz , J. , Bansal , S. , Malhotra , C. and Schwacha , M. G. 1989 . Effect of yohimbine hydrochloride on erectile impotence: a double blind study . Journal of Urology , 141 : 1360 – 1363 .
   PubMed Web of Science ®Google Scholar
• Virag , R. 1982 . Intracavernous injections of papaverine for erectile failure . Lancet , ii : 938
   Google Scholar
• Virag , R. and Adakian , P. G. 1987 . Effects of prostaglandin E1 on penile erection and erectile failure. Letter to the Editor . Journal of Urology , 137 : 1010
   PubMed Web of Science ®Google Scholar
• Williams , G. . The role of intraurethral therapy in the management of erectile dysfunction . paper presented at the British Erectile Disorder Society Annual Conference . Stratford on Avon.
   Google Scholar
• Witherow , R. 1996 . Surgical management of erectile dysfunction . International Journal of STD & AIDS , 7 ( suppl. 3 ) : 19 – 21 .
   PubMed Web of Science ®Google Scholar